Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Licensing opportunity from NIH: broad-spectrum chemokine antagonist

July 22, 1999

Amgen reveals latest in inhibitors of matrix metalloproteinases

July 21, 1999

New Amgen compounds for disorders mediated by TNF-alpha, collagenase and/or stromelysin

July 20, 1999

MGI Pharma to copromote rheumatology product with Pharmacia & Upjohn

July 19, 1999

Inhibitors of caspases undergo joint development at Warner-Lambert and BASF

July 19, 1999

New label sought for Enbrel in early, active RA

July 16, 1999

AdProTech presents data on its membrane-active complement inhibitor

July 16, 1999

CSAID from Italfarmaco prevents de novo formation of B1 receptors

July 15, 1999

New series from Novo Nordisk useful for pain, inflammation, NIDDM, etc.

July 15, 1999

TT-232, a new somatostatin analogue, effective against neurogenic and non-neurogenic inflammation

July 14, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...